Compare Stocks → Altcoin FRENZY Alert… (From Crypto 101 Media) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:AEMDOTCMKTS:BNOEFNASDAQ:ONCSCVE:SNG Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAEMDAethlon Medical$1.73-1.1%$1.75$1.40▼$7.20$4.53M1.8910,429 shs6,749 shsBNOEFBionomics$0.00-43.3%$0.00$0.00▼$0.06$4.45M1.86140,299 shs22,900 shsONCSOncoSec Medical$0.52$0.18▼$20.46$1.26M1.992.22 million shs52.49 million shsSNGSilver Range ResourcesC$0.07-6.7%C$0.07C$0.06▼C$0.17C$6.65M-0.0331,616 shs4,833 shsThese 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAEMDAethlon Medical-1.14%+5.49%-1.14%-20.64%-54.47%BNOEFBionomics0.00%0.00%0.00%0.00%-77.33%ONCSOncoSec Medical0.00%0.00%0.00%0.00%-87.73%SNGSilver Range Resources0.00%0.00%+7.69%-39.13%-41.67%CBOE shift unlocks new weekend income strategy (Ad)You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange. You're probably wondering, “Okay… But how does that affect me?” This perk now allows everyday traders like yourself to target extra income over the weekend. Check out this training for the full story! MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAEMDAethlon Medical1.7049 of 5 stars3.53.00.00.02.30.00.6BNOEFBionomicsN/AN/AN/AN/AN/AN/AN/AN/AONCSOncoSec MedicalN/AN/AN/AN/AN/AN/AN/AN/ASNGSilver Range ResourcesN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAEMDAethlon Medical3.00Buy$10.00478.03% UpsideBNOEFBionomicsN/AN/AN/AN/AONCSOncoSec MedicalN/AN/AN/AN/ASNGSilver Range ResourcesN/AN/AN/AN/ACurrent Analyst RatingsLatest BNOEF, AEMD, SNG, ONCS, and 1AD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/4/2024AEMDAethlon MedicalHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$23.00 ➝ $10.00(Data available from 3/28/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAEMDAethlon Medical$570K7.95N/AN/A$6.56 per share0.26BNOEFBionomicsN/AN/AN/AN/AN/AN/AONCSOncoSec MedicalN/AN/AN/AN/A$3.42 per shareN/ASNGSilver Range ResourcesN/AN/AC$0.00 per share16.25C$0.11 per shareN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAEMDAethlon Medical-$12.03M-$4.99N/AN/AN/AN/A-106.28%-86.60%6/26/2024 (Estimated)BNOEFBionomicsN/AN/A0.00∞N/AN/AN/AN/AN/AONCSOncoSec Medical-$34.18M-$15.29N/AN/AN/AN/A-868.29%-160.61%N/ASNGSilver Range Resources-C$1.69M-C$0.02N/A∞N/AN/A-16.23%-9.12%N/ALatest BNOEF, AEMD, SNG, ONCS, and 1AD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails2/14/2024Q3 2024AEMDAethlon Medical-$1.23-$1.37-$0.14-$1.37N/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAEMDAethlon MedicalN/AN/AN/AN/AN/ABNOEFBionomicsN/AN/AN/AN/AN/AONCSOncoSec MedicalN/AN/AN/AN/AN/ASNGSilver Range ResourcesN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAEMDAethlon MedicalN/A3.933.93BNOEFBionomicsN/AN/AN/AONCSOncoSec MedicalN/A0.890.89SNGSilver Range Resources0.075.827.93OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAEMDAethlon Medical1.99%BNOEFBionomicsN/AONCSOncoSec Medical8.69%SNGSilver Range ResourcesN/AInsider OwnershipCompanyInsider OwnershipAEMDAethlon Medical4.00%BNOEFBionomicsN/AONCSOncoSec Medical1.32%SNGSilver Range Resources38.33%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableAEMDAethlon Medical152.62 million2.52 millionOptionableBNOEFBionomicsN/A1.31 billionN/ANot OptionableONCSOncoSec Medical404.55 million4.49 millionNot OptionableSNGSilver Range ResourcesN/A94.97 millionN/ANot OptionableBNOEF, AEMD, SNG, ONCS, and 1AD HeadlinesSourceHeadlineHow Quinta Brunson Hacked the Sitcomnewyorker.com - March 18 at 9:43 AMTwo Veteran Hikers Launch Seniq, an Outdoor Wear Line Catering to Womenmsn.com - March 14 at 7:20 PMOct. 7: Rape as an instrument of genocideclevelandjewishnews.com - March 13 at 3:00 PMReview: Ariana Grande isn’t perfect, and neither is ‘eternal sunshine’nyunews.com - March 13 at 9:59 AMThree Wyoming Authors Awarded Western Writing's Highest Honorcowboystatedaily.com - March 13 at 9:59 AMSkyfire, the Canberra Comedy Festival, and the Balloon Spectacular: 50+ things to do this weekhercanberra.com.au - March 11 at 8:29 PMWhat’s happening around New Mexico February 23-29msn.com - February 23 at 1:38 PMGame-changer for NJ beauty services: These are salon suites in New Jerseynj1015.com - February 21 at 4:33 PMTHIS UNIVERSITY OF FLORIDA PROGRAM OFFERS INSIGHTS INTO SUSTAINABLE LANDSCAPINGkeysweekly.com - February 21 at 4:33 PMTexas tough: Defense shines when offense struggles in virtual must-win over Kansas Statemsn.com - February 20 at 7:40 AMUMG Nashville Launches Silver Wings Records, Signs Huestonyahoo.com - February 15 at 6:02 PMDr. Jeremy Silver: Heart health risk factors to be aware ofwgnradio.com - February 4 at 2:52 PMMultiplayer Strategy Game “RoboHero” Featuring Seamless Integration of Tokens and NFTs to Launch on WEMIX PLAYmarkets.businessinsider.com - February 4 at 9:52 AMLocal Author's Book Available at Carson Tahoe Medical Center gift shopcarsonnow.org - February 4 at 9:52 AMCarson High School debate team shines at home tournamentcarsonnow.org - January 31 at 2:37 PM23 Famous People With Amazing Hidden Talentsmsn.com - January 31 at 2:37 PMToday's events for Feb. 1postandcourier.com - January 31 at 2:37 PMMarket Melody: Decoding Silver’s Trends, Breakdowns, and Support Levelsnasdaq.com - January 23 at 2:49 AMMarket Melody: Decoding Silver’s Trends, Breakdowns, and Support Levelsnasdaq.com - January 23 at 2:49 AMPan American Silver's 2023 Silver Production Misses Targets, Gold In Range; 2024 Targets Set -- Commodity Commentmarketwatch.com - January 17 at 7:25 AM2024 Games you need to wishlist todaycclonline.com - January 16 at 12:48 PMSilver Weekly Price Forecast – Silver Continues to Test Overall Rangefxempire.com - January 7 at 2:30 PMClosing Bell: Silver Range Resources Ltd flat on Monday (SNG)theglobeandmail.com - December 18 at 12:46 AMSilver Dollar Resources (SLVDF) Price Target Increased by 15.07% to 1.19msn.com - December 16 at 6:55 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsAethlon MedicalNASDAQ:AEMDAethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego, California.BionomicsOTCMKTS:BNOEFBionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which is in phase 2 clinical trial for the treatment of social anxiety disorder and phase 2b to treat post-traumatic stress disorder. It also develops BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer and phase 1 clinical trial for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia.OncoSec MedicalNASDAQ:ONCSOncoSec Medical Incorporated, a late-stage immuno-oncology company, focuses on designing, developing, commercializing intra-tumoral DNA-based therapeutics to stimulate and augment anti-tumor immune responses for the treatment of cancer. The company's product pipeline includes KEYNOTE-695, which is in Phase 2 trial for the treatment of advanced melanoma; TAVO + SARS-CoV-2 spike glycoprotein, which is in Phase 1 clinical trial for the treatment of COVID-19; and TAVO + epacadostat + pembrolizumab, which is in Phase 1 clinical trial for the treatment of squamous cell carcinoma head and neck cancer. Its pipeline also comprises TAVO +nivolumab, which is in Phase 2 clinical trial for the treatment of breast cancer; TAVO + CXCL9 for the treatment of solid tumors; and OMS-100 and OMS-102, which are in Phase 2 clinical trial for the treatment of metastatic melanoma. OncoSec Medical Incorporated has clinical trial collaborations with Merck & Co., Inc. and its subsidiary in connection with the KEYNOTE-695 and KEYNOTE-890; and a research collaboration with Duke University's Center for Applied Therapeutics to evaluate TAVO in combination or sequenced with a HER2-plasmid vaccine. The company was formerly known as NetVentory Solutions Inc. and changed its name to OncoSec Medical Incorporated in March 2011. OncoSec Medical Incorporated was incorporated in 2008 and is headquartered in Pennington, New Jersey.Silver Range ResourcesCVE:SNGSilver Range Resources Ltd., a junior resource exploration company, engages in the acquisition, exploration, and evaluation of precious metal resources in Canada. The company explores for gold, silver, zinc, lead, and copper deposits. Its property portfolio comprises mineral properties located in Nevada, the Northwest Territories, Nunavut, and the Yukon Territory. Silver Range Resources Ltd. was incorporated in 2010 and is headquartered in Vancouver, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.